Wesley Pruitt, MD
Nephrology · Asheville, NCNPI 1255460200
Payments from drug & device makers
What this record shows
5 manufacturers reported payments, led by Nxstage Medical, Inc. at 26.4% of the total. Reporting peaked in 2024 at $37 and has fallen 93.5% since, to $2 in 2025. That places this record below the midpoint for nephrology clinicians in NC, where the typical reported total is $1,119.
Across 7 payments — averaging $14.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nxstage Medical, Inc.$27
- Travere Therapeutics, Inc.$23
- Amgen$20
- Vifor Pharma, Inc.$17
- Ultragenyx Pharmaceutical Inc.$16
What the payments were for
- Food & beverage$6058%
- Education$4442%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nxstage Medical, Inc. | 1 | $27 |
| Travere Therapeutics, Inc. | 3 | $23 |
| Amgen | 1 | $20 |
| Vifor Pharma, Inc. | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
How this compares
$104 in reported general payments places this provider in the 15th percentile of 366 nephrology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 79 | $58,149 |
| FarxigaDapagliflozin Propanediol | 26 | $21,941 |
| Sevelamer Carbonate | 43 | $11,567 |
| Chlorthalidone | 246 | $2,945 |
| Bumetanide | 68 | $2,266 |
| Torsemide | 91 | $1,705 |
| Clonidine | 15 | $1,521 |
| Calcium Acetate | 17 | $1,320 |
| Losartan Potassium | 160 | $1,319 |
| Amlodipine Besylate | 225 | $1,206 |
| Lisinopril | 170 | $952 |
| Furosemide | 102 | $817 |
| Midodrine Hcl | 43 | $734 |
| Metoprolol Succinate | 37 | $645 |
| Mycophenolate Mofetil | 11 | $641 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Asheville
- Nam VoAsheville$89K
- Gregory GreenwoodWinston-Salem$947K
- Michael EtomiCharlotte$212K
- William KendrickGreenville$125K
- Jason EckelCary$123K
- Raven VooraSanford$111K
- Jennifer StoddardPinehurst$77K
- Barry FreedmanWinston Salem$67K
- James McCabeWilmington$56K
- Sammy MoghaziRaleigh$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.